About developing new pharmaceuticals: apparently something that works well with mice might or might not eventually work with humans, and it's a slow and costly

About developing new pharmaceuticals: apparently something that works well with mice might or might not eventually work with humans, and it's a slow and costly process to notice this only at the end of phase III clinical trials. If someone comes up with a way to do hyper-accurate and fast in silico testing of human physiology, the duration of the clinical research would be dramatically shortened from the 10-15 years it takes nowadays. If this ever happens, the valuation of biotech companies creating pharmaceuticals will explode onto absurd levels (like internet companies did during the "IT bubble").